朗姿股份(002612) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was ¥891,900,081.96, representing a 52.06% increase compared to ¥586,527,134.59 in the same period last year[8] - Net profit attributable to shareholders was ¥35,205,507.60, a significant turnaround from a loss of ¥3,174,066.09, marking a 1,209.16% increase[8] - The net profit after deducting non-recurring gains and losses was ¥34,088,978.54, compared to a loss of ¥9,763,092.44, reflecting a 449.16% improvement[8] - The basic earnings per share increased to ¥0.0796 from a loss of ¥0.0073, representing a 1,190.00% increase[8] - The company reported a total comprehensive income of CNY 28.33 million for Q1 2021, a significant improvement from a loss of CNY 13.09 million in the same period last year[61] - The net profit for the first quarter of 2021 was CNY 18,506,895.60, a decrease of 15.5% compared to CNY 21,922,037.80 in the same period last year[64] - Total comprehensive income for the first quarter was CNY 18,617,742.70, down from CNY 21,922,037.80, reflecting a decline of approximately 15.5%[66] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,660,202,922.78, up 9.83% from ¥5,153,564,692.50 at the end of the previous year[8] - Total liabilities reached CNY 2,096,593,562.88, compared to CNY 1,556,811,255.18, marking an increase of around 34.7%[46] - Current liabilities rose to CNY 1,203,835,243.41, an increase from CNY 1,028,128,771.25, reflecting a growth of approximately 17.0%[46] - The total amount of entrusted financial management is CNY 59.9 million, with an outstanding balance of CNY 10.04769 million[34] - The company reported cash and cash equivalents of CNY 318.35 million as of March 31, 2021, an increase from CNY 291.01 million at the end of the previous period[42] - The company reported a total of CNY 1,943,281,348.08 in current assets, unchanged from the previous year[76] Cash Flow - The net cash flow from operating activities was ¥178,095,397.49, down 14.61% from ¥208,554,894.70 in the same period last year[8] - Cash flow from operating activities generated CNY 178,095,397.49, a decrease of 14.6% compared to 208,554,894.70 in the previous year[69] - Cash inflow from sales of goods and services was CNY 953,057,199.34, an increase of 19.9% from CNY 795,137,171.45 in the prior year[67] - The company reported cash outflows from operating activities totaling CNY 1,095,088,776.60, compared to CNY 594,560,763.97 in the same period last year, indicating a significant increase in operational expenses[69] - Investment activities resulted in a net cash outflow of CNY 281,433,587.17, worsening from a net outflow of CNY 125,031,108.46 in the previous year[69] - The total cash inflow from financing activities was 420,625,300.00 CNY, compared to 48,199,998.18 CNY in the previous year[74] Shareholder Information - The total number of shareholders at the end of the reporting period was 62,660, with the largest shareholder holding 47.82% of the shares[12] - The company reported a performance commitment to not transfer shares for 36 months from the date of listing or until the performance compensation obligations are fulfilled, whichever is later[24] - New shares acquired through the acquisition cannot be transferred for 12 months from the date of issuance, ensuring compliance with regulatory requirements[24] - The company has committed to avoiding related party transactions and ensuring fair pricing in any necessary transactions post-acquisition[24] - The company has reported good compliance with its commitments regarding share lock-up periods and related transactions[24] Business Operations - As of the end of the reporting period, operating revenue increased by 52.06% year-on-year, driven by a strong recovery in the fashion women's wear and medical beauty sectors, with women's wear revenue reaching RMB 409.08 million, up 41.91%[18] - The medical beauty business achieved revenue of RMB 259.46 million, reflecting a significant growth of 92.03% year-on-year[18] - Sales expenses rose by 40.48% year-on-year, correlating with the expansion of sales scale during the reporting period[18] - The company is actively adjusting its women's clothing product structure and channel layout, contributing to steady business development and rapid growth in the medical beauty sector[33] - The company plans to continue expanding its market presence and investing in new product development to drive future growth[59] Investments - The company's investment in two medical beauty industry funds, 博辰五号 and 博辰八号, resulted in a 350.50% increase in other non-current financial assets compared to the beginning of the period[18] - The company completed a capital contribution of RMB 18.04 million to the 博辰五号 fund during the reporting period, with a total fund size of RMB 40.1 million[19] - The company also contributed RMB 9.7 million to the 博辰八号 fund, which has a total size of RMB 25.1 million[19] - Cash flow from investment activities decreased by 125.09% year-on-year, mainly due to investments in the medical beauty funds[18] Compliance and Governance - The company has established measures to avoid competition with its subsidiaries and ensure independence in operations, assets, and finances[26] - The actual controllers of the company have committed to not engage in any competitive business activities that could harm the company's interests[26] - The company has a long-term commitment to maintain independence and avoid conflicts of interest with its controlling shareholders[26] - The company is focused on protecting the interests of minority shareholders and ensuring transparency in operations[26] Future Projections - The forecasted net profit attributable to shareholders for the period from the beginning of the year to the next reporting period is expected to be between CNY 8 million and CNY 10 million, indicating a significant improvement compared to a loss of CNY 28.77 million in the same period last year[33] - The basic earnings per share is projected to be CNY 0.1808 to CNY 0.2260, reflecting a decrease of CNY 0.0066 compared to the previous year[33]